Government Contracts: Randox Laboratories

Alberto Costa Excerpts

Thursday 10th February 2022 Commons Chamber

[Maggie Throup]

I make no apologies for how we as a country rose to the challenge that we faced in early 2020. I think that sometimes we forget what this country—indeed, the world—was going through. We must remember those days, and I am sure that hon. Members across the House will agree that what we have put in place since will ensure that we can cope far better in the future. We do need to learn lessons, and we will learn lessons.

However, one of the most important lessons that I take from when we worked together is that we can do incredible things. The NHS has been phenomenal, our hospitals have been phenomenal, and local government has been phenomenal, as has the private sector. We have all worked together and we have really worked hard, and that is why we can now see that—with the vaccine programme as well, along with the therapeutics and antivirals—we are combating this virus. We could not have come this far without everybody working together, and this country’s testing structure has been crucial in helping us to get through this time. I would like to take this opportunity to thank everybody who has been involved in this huge effort both at testing sites and working in the lab, and everybody who has come forward to get tested to keep their loved ones safe.

I would like to respond to some of the questions posed by the hon. Lady. My Department did inform you, Mr Speaker, that we were unable to meet our initial deadline for responding to the Humble Address. That was mainly due to the surge of omicron at that time, and the way that my Department had to respond to ensure that we kept our citizens safe from that variant surge.

The hon. Lady raised the issue of the Randox kits that were recalled in the summer of 2020. It was on 15 July that year that NHS Test and Trace was notified that some kits produced by Randox laboratories may not have met the required standard for coronavirus testing. As a precautionary measure, while this was investigated further, NHS Test and Trace paused the use of these Randox test kits with immediate effect. It was on 7 August that the Medicines and Healthcare Products Regulatory Agency instructed Randox to recall the Randox covid-19 home testing kits with a specific catalogue number. That decision was taken as a precautionary measure to prevent any further use of these Randox tests. The risk to safety was low, and test results from Randox kits were not affected. An independent assessment in June 2020 had placed Randox ahead of other laboratories, and Randox was meeting its delivery targets by September 2020. We were very precautionary in the measures we put in place to ensure that we were protecting everybody at that time.

I did note the point of order that the hon Lady made this week about the meeting on 9 April 2020, which she has raised again today. The note was taken during the meeting, and it was saved in a draft folder of the private secretary who took the note. When the Department received a freedom of information request for the minute of the meeting, the private secretary found the minute and shared it. For clarity, “note” and “minute” mean an official record of a meeting; the words mean the same from that point of view.

I reiterate that there are robust rules and processes in place that ensure that contracts are awarded in accordance with the public procurement regulations of 2015, and that Ministers are not involved in the assessment and evaluation process for contracts at all. That is a really important principle that the Government work on now, and have worked on probably for decades, and that principle will never be broken.

[Alberto Costa (South Leicestershire) (Con)]

You will remember, Mr Speaker, as the right hon. Member for Chorley, and every Member in this House will remember, the enormous pressure we were all put under, barely two years ago, to try to find businesses and organisations that could quickly produce much-needed equipment and services to assist the people of our country during an unprecedented global pandemic. Can I put on record my appreciation of the enormous work that the Government did, and does the Minister agree with me that, had it not been for their work, we would not have been able to protect and save the lives of so many people in our country?

[Maggie Throup]

I appreciate my hon. Friend’s recognition, remembering where we were barely two years ago, of how we have moved on since then. We have put in place a test and trace programme that is renowned across Europe and across the world, and we have a world-leading vaccination programme as well as the amazing work done on therapeutics and antivirals. Coming together in the national effort has been vital, which is why I make no apologies for my Department’s looking at every opportunity to ensure that everybody could get tested who needed to be tested, that everybody could be jabbed who needed to be jabbed, and that the right therapeutics were in place to keep people safe.